Proliferating Arterial Smooth Muscle Cells After Balloon Injury Express TNF-α but Not Interleukin-1 or Basic Fibroblast Growth Factor
- 1 January 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 16 (1) , 12-18
- https://doi.org/10.1161/01.atv.16.1.12
Abstract
We have recently reported that balloon withdrawal injury to rabbit abdominal aortas induces sustained activation indicated by the expression of certain adhesion molecules such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in regenerating endothelial cells and/or proliferating smooth muscle cells (SMCs). Local cytokine signaling may contribute to ongoing modulation of cellular functions and proliferation of intimal SMCs after acute vascular injury. We therefore studied the expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), proinflammatory and SMC growth–promoting cytokines, and basic fibroblast growth factor (bFGF) in SMCs of rabbit aorta at 2 (n=4), 5 (n=4), and 10 days (n=6) after balloon injury. All animals were given bromodeoxyuridine (BrdU, 10 mg/kg per day) continuously to label proliferating SMCs. Frozen cross sections of injured vessels at each time point after balloon injury were examined by immunoperoxidase staining with monoclonal antibodies. As early as 2 days after injury, before intimal thickening begins, foci of medial SMCs expressed TNF-α, but not all TNF-α–positive medial SMCs had incorporated BrdU, suggesting that TNF-α expression by medial SMCs may precede their proliferation. At 5 days, TNF-α–bearing and BrdU-labeled medial SMCs increased in number. At 10 days after injury, when uniform intimal thickening occurred, almost all neointimal SMCs and foci of medial SMCs labeled with BrdU. Most of the BrdU-positive (proliferating) SMCs expressed immunoreactive TNF-α. Reverse transcription polymerase chain reaction showed increased TNF-α mRNA at 10 days after ballooning in the injured portion of the aorta. In contrast, regions of SMC proliferation showed inconsistent IL-1β expression, and bFGF, abundant in normal rabbit arteries, was not detected in areas of SMC replication. These data indicate that replication of arterial SMCs after balloon injury occurs in regions of TNF-α but not IL-1β expression and correlates inversely with the presence of bFGF. These results indicate that SMC-derived TNF-α serves as a marker of modulated SMC phenotype after acute vascular injury and may contribute to local cellular activation and proliferation of SMCs at sites of arterial injury.Keywords
This publication has 13 references indexed in Scilit:
- Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.Journal of Clinical Investigation, 1993
- Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.Proceedings of the National Academy of Sciences, 1992
- Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.Proceedings of the National Academy of Sciences, 1991
- Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.Journal of Clinical Investigation, 1990
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990
- Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.The Journal of Experimental Medicine, 1987
- Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.Proceedings of the National Academy of Sciences, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased MusclesScience, 1978